Phibro Animal Health (PAHC)
(Delayed Data from NSDQ)
$12.73 USD
+0.29 (2.33%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $12.71 -0.02 (-0.16%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PAHC 12.73 +0.29(2.33%)
Will PAHC be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for PAHC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PAHC
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
Abbott (ABT) Tops Q1 Earnings and Revenue Estimates
PAHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?
Phibro Stock (PAHC) Rises 7% YTD: Will the Run Continue?
Here's Why Investors Should Buy Phibro (PAHC) Stock Now
Other News for PAHC
Phibro Animal Health Corp. (PAHC) Shares Cross Below 200 DMA
Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results
Phibro Animal Health About To Put More Money In Your Pocket (PAHC)
Phibro Animal Health Corporation to Participate in Barclays Global Healthcare Conference
PAHC Makes Bullish Cross Above Critical Moving Average